The Trump administration is threatening the Fed’s autonomy, which the central bank regained with the Treasury-Fed accord in 1951.
Category: Hassett, Kevin A
-
Fed Divisions Underscore Challenge for Trump’s Next Chair
President Trump wants substantially lower borrowing costs, but officials at the central bank appear ready to resist delivering further cuts if the economic backdrop does not warrant it.
-
Trump’s Search for Powell’s Replacement Adds to Cacophony Around Interest Rate Decision
The end of Jerome Powell’s term as Fed chair will give President Trump his biggest opportunity yet to reshape the central bank.
-
Why Markets Are Getting Anxious About the Fed
The central bank is widely expected to lower its benchmark lending rate on Wednesday. But investors are worried about what comes afterward.
-
Powell Faces Pressure From Multiple Fronts as Fed Prepares to Cut Rates
The chair of the central bank is dealing with internal divisions while being besieged by President Trump and front-runners jockeying to replace him.
-
Markets Defy the White House
Volatility has returned to stocks and crypto trading, despite assurances from a top administration official, as investors brace for more data on consumers.
-
Kevin Hassett Reportedly Becomes Front-Runner for Fed Chair
Kevin Hassett, a top White House economic adviser , is said to become the front-runner to lead the Federal Reserve, raising questions about its independence.
-
Soybeans Were America’s Biggest Export to China. Now, Sales Are Down to Zero.
China stopped buying soybeans from America in May, placing a retaliatory tariff on the bumper crop after President Trump increased levies on goods from China.
-
Second Weak Jobs Report Undercuts Trump’s Claims of a Booming Economy
After a bad employment report in August, President Trump fired the official in charge of the numbers. This month’s data was just as disappointing.
-
After U.S. Takes Stake in Intel, Trump Pledges ‘Many More’ Deals
The president said he hoped to “get as much as I can,” signaling a shift in the relationship between government and private business.
-
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat
The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.
-
Bluffs and Bluster Aside, Trump’s Tariffs Are Here to Stay
The president has earned a reputation for bluffing on tariffs. But he has steadily and dramatically raised U.S. tariffs, transforming global trade.